Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Document › Details

Merck KGaA. (8/3/17). "Press Relase: Executive Board Changes at Merck". Darmstadt.

Organisations Organisation Merck KGaA
  Group Merck (DE) (Group)
  Organisation 2 Merck (DE) (Group)
Products Product chemistry (science)
  Product 2 LIFE SCIENCES
Persons Person Beckmann, Kai (Merck KGaA 201709– Executive Board Member for Performance Materisl before Human Resources)
  Person 2 Garijo, Belén (Merck (DE) 202007– promoted Deputy CEO before CEO of Merck Serono before COO before Sanofi)
     


The Personnel Committee of E. Merck KG has decided on changes in the responsibilities of the Executive Board of Merck KGaA, Darmstadt, effective September 1, 2017.

> Kai Beckmann to assume responsibility for the Performance Materials business sector

> Walter Galinat takes over responsibility for the Darmstadt site, Procurement as well as Environment and Quality


The Personnel Committee of E. Merck KG has decided on changes in the responsibilities of the Executive Board of Merck KGaA, Darmstadt, effective September 1, 2017.

Walter Galinat (61) will hand over responsibility for the Performance Materials business of Merck to his Executive Board colleague Kai Beckmann (51). In return, Galinat will take on Executive Board responsibility for the Darmstadt site, Procurement as well as Environmental Protection, Quality and Safety.

“With these changes to the Executive Board, we are underscoring personnel continuity within the Board while setting the course for the future of Performance Materials,” said Johannes Baillou, Chairman of the Board of Partners of E. Merck KG and its Personnel Committee. In addition, in his new role Galinat will further advance both the construction and organizational preparations for the 350th anniversary celebration of Merck in 2018.

“Over the past decade, Walter Galinat has led Performance Materials from one success to the next. We are very grateful to him for this. At the same time, we are pleased to continue building on his vast wealth of experience,” said Baillou. “As an experienced member of Merck’s Executive Board, Kai Beckmann has extensive business, technological and international expertise, among other things from the very important Asian market. For him and for Merck, the aim now is to build on the long and successful development of Performance Materials, leading it into the future in times of increasingly dynamic developments in the liquid crystals market.”

Belén Garijo (57), CEO Healthcare, will additionally take over Executive Board responsibility for Group Human Resources from Kai Beckmann. Udit Batra (46), CEO Life Science, will be responsible for Business Technology, in other words the IT landscape of the Merck Group. In addition to his role as Chief Financial Officer, Marcus Kuhnert (48) will be responsible for Merck Business Services, a newly formed unit.

CVs of the Members of the Executive Board can be found here.


For more information, contact Thomas Moeller
+49 6151 72 62445
Email


All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.


About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

   
Record changed: 2023-06-05

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top